Order Article Reprints

Parigi TL, Allocca M, Furfaro F, D’Amico F, Zilli A, Dal Buono A, Gabbiadini R, Bonovas S, Armuzzi A, Danese S, et al. Treat-to-Target and Regular Surveillance of Inflammatory Bowel Disease Are Associated with Low Incidence and Early-Stage Detection of Malignancies: A Retrospective Cohort Study. Cancers. 2023; 15(24):5754. https://doi.org/10.3390/cancers15245754

Parigi, Tommaso Lorenzo, Mariangela Allocca, Federica Furfaro, Ferdinando D’Amico, Alessandra Zilli, Arianna Dal Buono, Roberto Gabbiadini, Stefanos Bonovas, Alessandro Armuzzi, Silvio Danese, and et al. 2023. "Treat-to-Target and Regular Surveillance of Inflammatory Bowel Disease Are Associated with Low Incidence and Early-Stage Detection of Malignancies: A Retrospective Cohort Study" Cancers 15, no. 24: 5754. https://doi.org/10.3390/cancers15245754

Parigi, T. L., Allocca, M., Furfaro, F., D’Amico, F., Zilli, A., Dal Buono, A., Gabbiadini, R., Bonovas, S., Armuzzi, A., Danese, S., & Fiorino, G. (2023). Treat-to-Target and Regular Surveillance of Inflammatory Bowel Disease Are Associated with Low Incidence and Early-Stage Detection of Malignancies: A Retrospective Cohort Study. Cancers, 15(24), 5754. https://doi.org/10.3390/cancers15245754